Eosinophilic diseases of the gastrointestinal tract

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 9, 2010, Pages 1013-1021

  Lucendo, Alfredo J ^a  

^a HOSPITAL GENERAL DE TOMELLOSO   (Spain)

Author keywords

Eosinophilic colitis; Eosinophilic esophagitis; Eosinophilic gastroenteritis; Eosinophils; Hypereosinophilic syndrome

Indexed keywords

18 HYDROXYHYDROCORTISONE; AZATHIOPRINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; INFLIXIMAB; KETOTIFEN; MEPOLIZUMAB; MERCAPTOPURINE; MONTELUKAST; OMALIZUMAB; STEROID;

AVOIDANCE BEHAVIOR; CLINICAL FEATURE; DIET THERAPY; EOSINOPHILIC COLITIS; EOSINOPHILIC ENTERITIS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTRITIS; EOSINOPHILIC GASTROINTESTINAL DISORDER; ESOPHAGUS DILATATION; FOOD ALLERGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOMODULATION; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEROID THERAPY;

EOSINOPHILIA; GASTROINTESTINAL DISEASES; HUMANS;

EID: 77955519632     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003690251     Document Type: Review

References (68)

1. Behm CA, Ovington KS. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today 2000;16:202-209
2. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
3. Weller PF, Lim K, Wan HC, Dvorak AM, Wong DT, Cruikshank WW, et al. Role of the eosinophil in allergic reactions. Eur Respir J Suppl 1996;22:109s-115s.
4. Butterworth AE. Cell-mediated damage to helminths. Adv Parasitol 1984;23:143-235.
5. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastroeintestinal eosinophils. Immunol Rev 2001;179:139-155
6. Rothenberg ME. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol 2004;113:11-28.
7. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, GoldmanH. Intraepitelial eosinophils: a new diagnostic criterion for reflux esophagitis.Gastroenterology 1982;83:818-823
8. Brown LF, Goldman H, Antonioli DA. Intraepitelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984;8:899-905.
9. Walsh RE, Gaginella TS. The eosinophil in inflammatory bowel disease. Scand J Gastroeneterol 1991;1217-1224
10. Dvorak AM. Ultrastructural evidence for release of major basic protein-containing crystaline cores of eosinophil granules in vivo: cytotoxic potential in Cronhs disease. J Immunol 1980;125:462.
11. Sarin SK, Malhotra V, Sen Gupta S, Karol A, Gaur SK, Anand BS. Significant eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 1978;32:363-367
12. Desreumaux P, Nutten S, Colombel JF. Activated eosinophils in inflammatory bowel disease: do they matter? Am J Gastroenterol 1999;94:189-195
13. Nishitani H, Okabayashi M, Satomi M, Shimoyama T, Dohi Y. Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis. J Gastroenterol 1998;33:189-195
14. Mueller S. Classification of eosinophilic gastrointestinal diseases. Best Pract Res Clin Gastroenterol 2008;22: 425-440
15. Kaijser R. Zur Kenntnis der allergischen Affektioner desima Verdeanungaskanal von Standpunkt desmia Chirurgen aus. Arch Klin Chir 1937;188:36-64.
16. Furuta GT, Forbes D, Boey C, Dupont C, Putnam P, Roy SK, et al. Eosinophilic Gastrointestinal Diseases Working Group. Eosinophilic gastrointestinal diseases (EGIDs). J Pediatr Gastroenterol Nutr 2008;47:234-238
17. Cherian S, Smith NM, Forbes DA. Rapidily increasing prevalence of eosinophilic esophagitis in Western Australia. Arch Dis Child 2006;91:1000-1004
18. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005;3;1198-1206
19. Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007;212:441-452
20. Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 2009;15:128-133
21. Ronkanien J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, et al. Prevalence of esophageal eosinophils and eosinophilic esophagitis in adults: the population-based Kalixandra study. Gut 2007;56:615-620
22. Gonsalves N. Food allergy and eosinophilic gastrointestinal illness. Gastroenterology Clin North Am 2007;36:75-91.
23. Pratt CA, Demain JG, Rathkopf MM. Food allergy and eosinophilic gastrointestinal disorders: guiding our diagnosis and treatment. Curr Probl Pediatr Adolesc Health Care 2008;38:170-188
24. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009;104:828-833
25. Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific elimination diet directed by a combination of skin prick and patch test. Ann Allergy Asthma Immunol 2005;95:336-343
26. Collins MH, Blanchard C, Albonia JP, Kirby C, Akers R, Wang N, et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol 2008;6: 621-629
27. Spechler SJ, GentaRM,Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007;102: 1301-1306
28. Merwat SN, Spechler SJ. Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am J Gastroenterol 2009;104:1902.
29. Mishra A., Hogan S.P., Brandt E.B., Rothenberg M.E. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002;168: 2464-2469.
30. Mishra A,Rothenberg ME. Intratracheal IL-13induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003;125: 1419-1427.
31. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002;168:2464-9.
32. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536-547
33. LucendoAJ,DeRezendeL,ComasC,CaballeroT,BellonT. Treatment With topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol 2008;103: 2184-2193
34. Hogan SP, Rothenberg ME, Forbes E, Smart VE, Matthaei KI, Foster PS. Chemokines in eosinophilassociated gastrointestinal disorders. Curr Allergy Asthma Rep 2004;4:74-82.
35. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Esophageal remodeling in paediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007;119:206-212
36. Lee R. Marked eosinophilia in esophageal mucosal biopsies. Am J Surg Pathol 1985;7:479.
37. Ruchelli E, Wenner W, Voytek T, Brown K, Liacouras C. Severity of esophageal eosinophilia predict response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 1999;2:15-18.
38. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995;109:1503-1512
39. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109-116
40. Liacouras CA, Bonis P, Putman PE, Straumann A, Ruchelli E, Gupta SK, et al. Summary of the first international gastrointestestinal eosinophil research symposium. J Pediatr Gastroenterol Nutr 2007;45:370-391
41. Liacouras C. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr 2003;37:S23-8.
42. Lucendo Villarín AJ, De Rezende L. Eosinophilic esophagitis. Review of current clinical and physiopathological concepts. Gastroenterol Hepatol 2007;30:234-241
43. Molina-Infante J, Hernández-Alonso M, Pérez-Gallardo B, Martin-Noguerol E. The first Asian case report of eosinophilic esophagitis in an asymptomatic adult: what about a proton pump inhibitor trial? J Chin Med Assoc 2009;72: 166-167
44. Noel RJ, Putman PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2001;26:940-941
45. Lucendo AJ, Pascual-Turrin JM, Navarro M, Comas C, Castillo P, Letrán A, et al. Endoscopic, bioptic and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy 2007;39:765-771
46. Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis (EE). A retrospective comparative pathologic biopsy study. J Clin Pathol 2006; DOI:10.1136/jcp.2005.031922. (Pubitemid 44787138)
47. Dellon ES,Aderroju A,Woosley JT,Sandler RS,Shaheen NJ. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007; 102: 1-14/
48. Lucendo Villarin AJ. Eosinophilic esophagitis-clinical manifestations, diagnosis, and treatment. Rev Esp Enferm Dig 2009;101:49-59.
49. Freeman HJ. Adult eosinophilic gastroenteritis and hypereosinophilic syndromes. Wordl J Gastroenterol 2008;14: 6771-6773
50. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990;31:58.
51. Yun MY, Cho YU, Park IS, Choi SK, Kim SJ, Shin SH, et al. Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature. World J Gastroenterol 2007;13:1758-1760
52. Katz AJ, Twarog FJ, Zeiger RS, Falchuk ZM. Milk-sensitive and eosinophilic gastroenteropathy: similar clinical features with contrasting mechanisms and clinical course. J Allergy Clin Immunol 1984;74:72-78
53. Navajas Leon FJ, Lucendo Villarin AJ, Erdozain Sosa JC, Carrion Alonso G, Martin Chavarri S, Gomez Senent S, et al. Eosinophilia and actinic enteritis due to radiotherapy for prostatic adenocarcinoma. Rev Esp Enferm Dig 2005;97:759-761
54. Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003;36:79-94.
55. Jeziorska M, Haboubi N, Schofield P, Woolley DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 2001;194:484-492
56. Rubin M. Allergic intestinal bleeding in the newborn. Am J Med Sci 1940;200.
57. Boné J, Claver A, Guallar I. Proctocolitis alérgica, enterocolitis inducida por alimento: mecanismos immunes, diagnstico y tratamiento. Allergol Immunopathol (Madr) 2008;36 (suppl 1):25-31.
58. Kilshaw PJ, Cant AJ. The passage of maternal dietary proteins into human breast milk. Int Arch Allergy Appl Immunol 1984;75:8-15.
59. Machida HM, Catto-Smith AG, Gall DG, Trevenen C, Scott RB. Allergic colitis in infancy: clinical and pathological aspects. J Pediatr Gastroenterol Nutr 1994;19:26.
60. Sicherer SH, Eigenmann PA, Sampson HA. Clinical features of food protein-induced enterocolitis syndrome. J Pediatr 1998;133:219.
61. Chusid MJ, Dale DC, West BC, Wolf SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54:1-27.
62. Anderson RE, Hardy WR. Hypereosinophilia. Ann Intern Med 1968;69:1331-1332
63. Straumann A. Idiopathic eosinophilic gastrointestinal diseases in adults. Best Pract Res Clin Gastroenterol 2008;22: 496.
64. Klion AD, Noel P, Akin C, Law MA, Gilliland DG, Cools J, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003; 101:4660-4666
65. Klion AD. Recent advances in the diagnosis and treatment of hypereosinophilic syndromes. Hematology Am Soc Hematol Educ Program 2005;209-214
66. Klion AD, Robyn JA, Akin C, Noel P, Brown M, Law M, et al. Molecular remision and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004;103:473-478
67. Stone KD, Prussin C. Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy 2008;38:1858-1865
68. Peterson KA, Thomas KL, Hilden K, Emerson LL, Wills JC, Fang JC. Comparasion of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2009, in press.